Finally, the results of univariable and multivariate Cox analyses revealed that SSR2 could be served as an independent prognostic factor for HCC patients (HR = 2.1.759, 95% CI 1.191-2.599, P = 0.004) in TCGA. Here, SSR2 is linked to hepatocellular carcinoma.